Breaking

Europe and US briefly upped the pressure on Russia over Ukraine. Trump upended that
Missiles, drones and airstrikes, until a sudden ceasefire. How India and Pakistan agreed to an uneasy truce
In China, some see the ghost of Mao as Trump upends America and the world
Pope! Amigo! Peruvians remember the young American priest who became pope
Dozens of boxes of Nazi materials found in basement at top Argentinian court
India and Pakistan both claim victory. But this latest conflict has no winners
A bridge builder and quiet reformer. How Pope Leo will lead the Catholic Church
Acceleration of RAD204 Phase 1 dose escalation trial

Facebook
Twitter
Google Plus
Instagram
Pinterest
Vimeo

Investing
Stock
Latest News
Editor’s Pick
Economy
Search for:

Investing

Radiopharm achieves Nasdaq listing of ADS

By November 27, 2024

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced Radiopharm achieves Nasdaq listing of ADS

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Acceleration of RAD204 Phase 1 dose escalation trial

Multiple New Multi-Commodity Targets

Excellent Gold Intersections Verified at Kiimala Project

Enter Your Information Below To Receive Latest News, And Articles.
Your name

Your email
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest Posts
Categories
- Economy (813)
- Editor's Pick (414)
- Investing (3,018)
- Latest News (3,071)
- Stock (1,161)
About Rightinvestingway

Disclaimer: Rightinvestingway.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 Rightinvestingway.com

Top

Type above and press Enter to search. Press Esc to cancel.